457 related articles for article (PubMed ID: 7544898)
1. Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening.
Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
Prenat Diagn; 1995 Jun; 15(6):555-65. PubMed ID: 7544898
[TBL] [Abstract][Full Text] [Related]
2. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.
Alldred SK; Takwoingi Y; Guo B; Pennant M; Deeks JJ; Neilson JP; Alfirevic Z
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012600. PubMed ID: 28295158
[TBL] [Abstract][Full Text] [Related]
3. Down's syndrome screening in multiple pregnancies using alpha-fetoprotein and free beta hCG.
Spencer K; Salonen R; Muller F
Prenat Diagn; 1994 Jul; 14(7):537-42. PubMed ID: 7526363
[TBL] [Abstract][Full Text] [Related]
4. Four-marker serum screening for Down's syndrome.
Wald NJ; Densem JW; Smith D; Klee GG
Prenat Diagn; 1994 Aug; 14(8):707-16. PubMed ID: 7527537
[TBL] [Abstract][Full Text] [Related]
5. The effect of temporal variation in biochemical markers of trisomy 21 across the first and second trimesters of pregnancy on the estimation of individual patient-specific risks and detection rates for Down's syndrome.
Spencer K; Crossley JA; Aitken DA; Nix AB; Dunstan FD; Williams K
Ann Clin Biochem; 2003 May; 40(Pt 3):219-31. PubMed ID: 12803832
[TBL] [Abstract][Full Text] [Related]
6. Effect of allowing for ethnic group in prenatal screening for Down's syndrome.
Watt HC; Wald NJ; Smith D; Kennard A; Densem J
Prenat Diagn; 1996 Aug; 16(8):691-8. PubMed ID: 8878277
[TBL] [Abstract][Full Text] [Related]
7. The use of free beta-hCG in antenatal screening for Down's syndrome.
Wald N; Densem J; Stone R; Cheng R
Br J Obstet Gynaecol; 1993 Jun; 100(6):550-7. PubMed ID: 7687460
[TBL] [Abstract][Full Text] [Related]
8. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong.
Lam YH; Ghosh A; Tang MH; Tang LC; Lee CP; Sin SY; Ho PK
Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604
[TBL] [Abstract][Full Text] [Related]
9. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Wald NJ; Watt HC
Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
Hsu JJ; Hsieh TT; Soong YK; Spencer K
Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
[TBL] [Abstract][Full Text] [Related]
11. Maternal smoking: age distribution, levels of alpha-fetoprotein and human chorionic gonadotrophin, and effect on detection of Down syndrome pregnancies in second-trimester screening.
Crossley JA; Aitken DA; Waugh SM; Kelly T; Connor JM
Prenat Diagn; 2002 Mar; 22(3):247-55. PubMed ID: 11920904
[TBL] [Abstract][Full Text] [Related]
12. Maternal serum free alpha-human chorionic gonadotrophin levels in twin pregnancies: implications for screening for Down's syndrome.
Wald NJ; Densem JW
Prenat Diagn; 1994 Aug; 14(8):717-9. PubMed ID: 7527538
[TBL] [Abstract][Full Text] [Related]
13. Screening of maternal serum for fetal Down's syndrome in the first trimester.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Miller WA; Johnson A
N Engl J Med; 1998 Apr; 338(14):955-61. PubMed ID: 9521983
[TBL] [Abstract][Full Text] [Related]
14. First-trimester urine free beta hCG, beta core, and total oestriol in pregnancies affected by Down's syndrome: implications for first-trimester screening with nuchal translucency and serum free beta hCG.
Spencer K; Noble P; Snijders RJ; Nicolaides KH
Prenat Diagn; 1997 Jun; 17(6):525-38. PubMed ID: 9203211
[TBL] [Abstract][Full Text] [Related]
15. Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.
Cuckle HS; Holding S; Jones R; Groome NP; Wallace EM
Prenat Diagn; 1996 Dec; 16(12):1095-100. PubMed ID: 8994244
[TBL] [Abstract][Full Text] [Related]
16. Dimeric inhibin A as a marker for Down's syndrome in early pregnancy.
Aitken DA; Wallace EM; Crossley JA; Swanston IA; van Pareren Y; van Maarle M; Groome NP; Macri JN; Connor JM
N Engl J Med; 1996 May; 334(19):1231-6. PubMed ID: 8606718
[TBL] [Abstract][Full Text] [Related]
17. Appropriate biochemical parameters in first-trimester screening for Down syndrome.
Cuckle HS; van Lith JM
Prenat Diagn; 1999 Jun; 19(6):505-12. PubMed ID: 10416963
[TBL] [Abstract][Full Text] [Related]
18. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol.
Extermann P; Bischof P; Marguerat P; Mermillod B
Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261
[TBL] [Abstract][Full Text] [Related]
19. Comparison of second-trimester maternal serum free-beta-human chorionic gonadotropin and alpha-fetoprotein between normal singleton and twin pregnancies: a population-based study.
Zheng MM; Hu YL; Zhang CY; Ru T; Liu QL; Xu BY; Chen QG; Xu ZF; Zhang Y; Zhong XL
Chin Med J (Engl); 2010 Mar; 123(5):555-8. PubMed ID: 20367980
[TBL] [Abstract][Full Text] [Related]
20. Screening for Down's syndrome: changes in marker levels and detection rates between first and second trimesters.
Berry E; Aitken DA; Crossley JA; Macri JN; Connor JM
Br J Obstet Gynaecol; 1997 Jul; 104(7):811-7. PubMed ID: 9236646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]